Trial · NCT01976871
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Proportion of Patients Completing the Switch and Their Adverse Events | Oral Dopamine Agonist to Rotigotine | Oral dopamine agonist to rotigotine switch success | 17 | participants | |
| Proportion of Patients Completing the Switch and Their Adverse Events | Oral Dopamine Agonist to Rotigotine | CGI-I responders (much or very much improved) | 14 | participants | |
| Proportion of Patients Completing the Switch and Their Adverse Events | Oral Dopamine Agonist to Rotigotine | Withdrew due to lack of efficacy | 3 | participants | |
| International Restless Legs Scale (IRLS) | Oral Dopamine Agonist to Rotigotine | Baseline (Day 1) IRLS score | 19.4 | Standard Deviation 5.5 | units on a scale |
| International Restless Legs Scale (IRLS) | Oral Dopamine Agonist to Rotigotine | Week 5 IRLS score | 12.7 | Standard Deviation 7.7 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Baseline RLS symptoms at bedtime | 3.9 | Standard Deviation 3.2 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Week 5 RLS symptoms at bedtime | 3.0 | Standard Deviation 3.1 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Baseline RLS symptoms during the night | 2.5 | Standard Deviation 2.3 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Week 5 RLS symptoms during the night | 2.1 | Standard Deviation 3.0 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Baseline RLS symptoms during the day at rest | 2.8 | Standard Deviation 2.5 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Week 5 RLS symptoms during the day at rest | 1.4 | Standard Deviation 2.4 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Baseline RLS symptoms during daily activities | 1.4 | Standard Deviation 2.2 | units on a scale |
| RLS-6 Scale | Oral Dopamine Agonist to Rotigotine | Week 5 RLS symptoms during daily activities | 0.9 | Standard Deviation 2.2 | units on a scale |
| Preference of Medication Scale (POM) | Oral Dopamine Agonist to Rotigotine | Much better, I prefer this med | 13 | participants | |
| Preference of Medication Scale (POM) | Oral Dopamine Agonist to Rotigotine | Slightly better | 2 | participants | |
| Preference of Medication Scale (POM) | Oral Dopamine Agonist to Rotigotine | About the same | 0 | participants | |
| Preference of Medication Scale (POM) | Oral Dopamine Agonist to Rotigotine | Slightly worse | 2 | participants | |
| Preference of Medication Scale (POM) | Oral Dopamine Agonist to Rotigotine | Much worse, I much prefer my previous med | 3 | participants | |
| The Patient Global Impression of Change Scale | Oral Dopamine Agonist to Rotigotine | Very much improved since baseline | 12 | participants | |
| The Patient Global Impression of Change Scale | Oral Dopamine Agonist to Rotigotine | Much improved | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01976871/results